Triochem Products Ltd. — Interim / Quarterly Report 2021

Feb 12, 2021

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 31580 Fax: 00 91 (22) 2202 4657 E-mail: info@amphray.com Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

Ref No: TPL PP 201229 2020; 12^th February 2021

To BSE Limited Corporate Relationship Department, Phiroze Jeejeebhov Towers, Dalal Street, Fort, Mumbai: 400 001. Security Code No. 512101 - ISIN No.: INE331E01013.

Dear Sir / Madam,

Sub: Outcome of the Board - Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015

Pursuant to Notice of Board meeting dated 2^nd February 2021 the Board meeting was held on today Friday, 12^th February, 2020 at 2.00 p.m. at 4^th Floor, Sambava Chambers, Sir P. M. Road, Fort, Mumbai: 400001 and has approved the following:

• 1. The Board approved the Unaudited Financial Results for the quarter and nine months ended on 31^st December 2020, as reviewed by the Audit Committee, in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
• 1. The Board noted and took on records the Limited Review Report for the quarter and nine months ended on 31^st December 2020 as placed before the Board.
• 1. Take notes on the compliance for the quarter and nine months ended 31^st December 2020
• 1. Board Meeting commenced at 2.00 p.m. and concluded at 3.10 p.m.

You are requested to take note of the same. Thanking you, Yours faithfully, For TRIOCHEM PRODUCTS LIMITED

RAMU S. DEORA DIRECTOR DIN: 00312369 Place: Mumbai $rod_{U_{c}}$

I(anu I)oshi Associates LLP

Chartered Accountants

Mumbai Address : 203, The Summit, Hanuman Road, Western Express Highway, Vlle PaTle (E), Mumbai - 400 057 T : 022-2615 0100 / 111 / 112 . F : 022 2615 0113

Pune Address : 123, Sohrab Hall, 21 Sassoon Road, Opp. Jet`angir Hospital, Pune -411001. T : 020 4906 7177 E : info@kdg.co.in . W : www,kdg.co.in

Independent Auditor's Review Report on unaudited Quarterly Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended)

TO,

The Board of Directors of TRIOCHEM PRODUCTS LIMITED ("Company")

• 1. We have reviewed the accompanying statement of unaudited financial results of TRIOCHEM PRODUCTS LIMITED ("Company") for the quarter and nine months ended December 31, 2020 being submitted by the Company pursuant to Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), including relevant circulars issued by SEBl from time to time. The statement is the responsibility of the Company's management and has been approved by Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review of the Statement, which has been prepared in acoordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("lnd As 34"), specified under Section 133 of the Companies Act, 2013, SEBI Circular CIFVCFD/PAC/62/2016 dated 5 July 2016 (hereinafter referred to as 'the SEBI Circular'), and other accounting principles generally accepted in India.
• 1. We conducted our review of the statement in accordance with the Standard on Review Engagement (SRE) 2410, `Review of Interim Financial Information performed by Independent Auditor of the Entfty' issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and an analytical procedure applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.
• 1. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian Accounting Standards (lnd AS) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement.

For Kanu Doshi Associates LLP Chartered Accountants Firm Registration No: 104746W/VV100096

KUNALsuMANTELfu#iTg¥ir##co VAKH A RiA ¥fa=:===:i-.

coo: anlni3 `.:eo.O +.ca

Kunal Vakharia Partner Membership No.: 148916 UDIN: 21148916AAAABR3677

Place: Mumbai Date: 12th February 2021

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2202 4657 E-mall: info@amphray.com Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

		TRIOCHEM PRODUCTS LIMITED
Registered Office : Sambava Chamber, 4th Floor, Sir P M Road, Fort, Mumbai - 400 001.
	Website: www.triochemproducts.com
CIN: L24249MH1972PLC015544 STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER, 2020
					(Rs in Lakh) Except EPS Nine Month Ended
Sr. No.	Particulars	Quarter Ended 30-Sep-20			31-Dec-19 31-Dec-20		Year Ended 31-Mar-20
		31-Dec-20 (Unaudited)	(Unaudited)	31-Dec-19 (Unaudited)	(Unaudited)	(Unaudited)	(Audited)
$\mathbf{1}$	Income
	(a) Revenue from Operations	394.50	225.86	541.16	620.36	855.52	2,003.18
	(b) Other Income	0.16	4.38	12.93	5.84	13.25	46.63
	Total Income From Operations	394.66	230.24	554.09	626.20	868.77	2,049.81
	Expenses
	(a) Cost of Materials Consumed	(0.00)	226.06	424.70	644.54	424.70	968.86
	(b) Purchase of stock in trade			4.78		4.78	37.55
	(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade	360.19	(47.76)	(99.57)	(111.88)	102.98	354.67
	(d) Employees Benefit Expenses	16.74	16.89	17.04	50.52	51.92	82.33
	(e) Finance Costs	2.47	4.97	9.36	9.53	17.19	22.97
	(f) Depreciation and Amortisation Expenses	3.46	3.46	4.21	10.34	12.57	16.68
	(g) Other Expenditure	21.40	33.79	27.33	75.23	84.93	111.57
	Total expenses	404.26	237.41	387.85	678.28	699.08	1,594.63
$\overline{\mathbf{3}}$	Profit before exceptional items and tax	(9.60)	(7.17)	166.24	(52.08)	169.69	455.18
$\overline{4}$	Exceptional items						$\bullet$
5	Profit/ (Loss) before tax	(9.60)	(7.17)	166.24	(52.08)	169.69	455.18
6	Tax Expense
	(a) Current tax	(0.00)		41.73	0.02	44.02	117.33
	(b) Deferred tax	(2.42)	(1.73)	1.71	(12.98)	(1.80)	(2.43)
$\mathsf{L}$	Total tax expenses	(2.43)	(1.73)	43.44	(12.97)	42.22	114.90
	Net Profit/ (Loss) for the period	(7.18)	(5.43)	122.80	(39.12)	127.47	340.28
	Other Comprehensive Income (Net of Taxes) (A)(i). Items that will be reclassified to profit or loss
	(ii). Income tax relating to items that will be reclassified to profit
	or loss
	(B)(i). Item that will not be reclassified to profit or loss	0.43	(1.06)	(0.03)	(0.52)	(0.32)	(0.30)
	(ii). Income tax relating to items that will not be reclassified to profit or loss	(0.11)	0.27		0.13	0.08	0.08
	Total other Comprehensive Income (net of taxes)	0.32	(0.79)	(0.03)	(0.39)	(0.24)	(0.22)
9	Total Comprehensive Income for the period	(6.85)	(6.22)	122.77	(39.50)	127.23	340.06
10	Paid-up equity share capital (Face Value of ₹ 10/- per share)	24.50	24.50	24.50	24.50	24.50	24.50
11	Other equity as per Balance Sheet of previous accounting year						1,193.14
12	Earnings per equity share (EPS) (of Rs. 10/- each) (not annualised)
	Basic / Diluted EPS (in Rs.)	(2.93)	(2.22)	50.12	(15.97)	52.03	138.89

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS Registered Office: 4^th Floor, Sambaya Chambers, Sir, P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2202 4657 E-mall: info@amphray.com Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

Place: Mumbai

Dated: 12th February, 2021

DIRECTOR & CEO

DIN: 00312369

Registered Office : Sambava Chamber, 4th Floor, Sir P M Road, Fort, Mumbai - 400 001.

Website: www.triochemproducts.com

CIN: L24249MH1972PLC015544

EXTRACT OF STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER, 2020

	(Rs in Lakh) Except EPS
Sr.	Particulars	Quarter Ended			Nine Month Ended		Year Ended
No.		31-Dec-20	30-Sep-20	31-Dec-19	31-Dec-20	31-Dec-19	31-Mar-20
				(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited)			(Audited)
$\mathbf{1}$	Net Operating Income	394.66	230.24	554.09	626.20	868.77	2,049.81
$\overline{2}$	Profit / (Loss) for the period (before Interest, Depreciation, Taxes, Exceptional and / or Extraordinary items)	(3.68)	1.26	179.81	(32.22)	199.45	494.83
$\overline{3}$	Profit / (Loss) for the period before tax (after Exceptional and / or Extraordinary items)	(9.60)	(7.17)	166.24	(52.08)	169.69	455.18
$\overline{4}$	Profit / (Loss) for the period after tax (after Exceptional and / or Extraordinary items)	(7.18)	(5.43)	122.80	(39.12)	127.47	340.28
$\overline{5}$	Total Comprehensive Income for the period [Comprising Profit / (Loss) for the period (after tax) and Other Comprehensive Income	0.32	(0.79)	(0.03)	(0.39)	(0.24)	(0.22)
$\vert 6 \vert$	Equity share capital (Face value of Rs. 10/- per share)	24.50	24.50	24.50	24.50	24.50	24.50
	Reserve (excluding Revaluation Reserves as shown in the Balance Sheet of previous year)						1.193.14
$\mathbf{3}$	Earnings per equity share (EPS) (of Rs. 10/- each) (for continuing and discontinued operations)
	a) Baisc (not annualized)	(2.93)	(2.22)	50.12	(15.97)	52.03	138.89
	b) Diluted (not ammualized)	(2.93)	(2.22)	50.12	(15.97)	52.03	138.89
Notes:
	1) The above unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 12th
	February, 2021. The Statutory auditors of the company has carried out a limited review of aforesaid results.
	2) The Audited financial results have been prepared in accordance with Indian Accounting Standards (Ins AS), the provisions of the Companies Act, 2013 (the
	Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI).

3) The Company operates in single segment only, i.e. chemical and pharmaceuticals; therefore, disclosure requirement of Indian Accounting Standard (IND) AS-108) "Segment Reporting" is not applicable.

4) Operations during the quarter continued to be impacted by measures to contain covid-19 pandemic. The business gathered momentum, though recovery has been gradual and partial. Accordingly, the results for the quarter are not comparable with those for the previous quarter and corresponding quarter of previous year. Based on the information available upto date, the Group expects to recover the carrying value of its assets.

5) The date of implementation of the Code on Wages, 2019 and the Code on Social Security 2020 is vet to be notified by the Government. The Ministry of Labour and Employment has released draft rules for the Code on Social Security 2020 on November 13, 2020, and has invited suggestions from Stakeholders which are under active consideration by the Ministry. The Company will assess the impact of these codes and give effect in the financial result when the Rules/Schemes thereunder are notified.

6) The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make them comparable wherever necessary

FOR TRIOCHEM PRODUCTS LIMITED

Place: Mumbai Dated: 12th February, 2021